Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

riociguat

riociguat
Drug Name Form Strength Notes
Adempas TABLET, ORAL 0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg
VIEW MORE Sclerosing Agents
Additional Information:

Riociguat is Formulary, Restricted to Patient’s Own Medication or continuation of home medication. 

 

September 11, 2026 update:  The FDA discontinued the Riociguat Shared System REMS program.  The goal of the Riociguat Shared System REMS was to mitigate the risk of embryo-fetal toxicity.

 

Last updated: Sep. 15, 2026
Rhazdrugs riociguat






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved